GlaxoSmithKline PLC (NYSE:GSK)

41.02
BATS BZX Real-Time Price
As of 1:14pm ET
 -0.02 / -0.05%
Today’s Change
34.52
Today|||52-Week Range
44.45
+15.65%
Year-to-Date
Large Cap Pharma Stock Outlook: Short-Term Struggle Likely
Jun 18 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication
Jun 14 / Zacks.com - Paid Partner Content
Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III
Jun 15 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Chevron, Glaxo, T-Mobile, Delta Air Lines and Amer...
Jun 14 / Zacks.com - Paid Partner Content
Company News For Jun 15, 2018
Jun 15 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Approval for Cervical Cancer
Jun 13 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals
Jun 15 / Zacks.com - Paid Partner Content
Top Stock Reports for Chevron, Glaxo & T-Mobile
Jun 13 / Zacks.com - Paid Partner Content
Mylan (MYL) to Get CRL Again for Generic Advair from FDA
Jun 14 / Zacks.com - Paid Partner Content
Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus
Jun 07 / Zacks.com - Paid Partner Content